{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:46:12Z","timestamp":1789980372776,"version":"4.0.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T00:00:00Z","timestamp":1521763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12941-018-0262-0","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T03:53:58Z","timestamp":1522814038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Comparison of nephrotoxicity of Colistin with Polymyxin B administered in currently recommended doses: a prospective study"],"prefix":"10.1186","volume":"17","author":[{"given":"Ritesh","family":"Aggarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Dewan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,23]]},"reference":[{"key":"262_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/cid\/ciu213","volume":"59","author":"RL Nation","year":"2014","unstructured":"Nation RL, Velkov T, Li J. Colistin and Polymyxin B: peas in a pod, or chalk and cheese? Clin Infect Dis. 2014;59:88\u201394.","journal-title":"Clin Infect Dis"},{"key":"262_CR2","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1128\/AAC.01733-10","volume":"55","author":"SM Garonzik","year":"2011","unstructured":"Garonzik SM, Li J, Thamlikitkul V, Paterson DL, Shoham S, Jacob J, Silveira FP, Forrest A, Nation RL. Population pharmacokinetics of Colistin methanesulfonate and formed Colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother. 2011;55:3284\u201394.","journal-title":"Antimicrob Agents Chemother"},{"key":"262_CR3","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/cid\/cit334","volume":"57","author":"AM Sandri","year":"2013","unstructured":"Sandri AM, Landersdorfer CB, Jacob J, Boniatti MM, Dalarosa MG, Falci DR, Behle TF, Bordinhao RC, Wang J, Forrest A, Nation RL, Li J, Zavascki AP. Population pharmacokinetics of intravenous Polymyxin B in critically ill patients: implications for selection of dosage regimens. Clin Infect Dis. 2013;57:524\u201331.","journal-title":"Clin Infect Dis"},{"key":"262_CR4","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1128\/AAC.02476-13","volume":"58","author":"K Phe","year":"2014","unstructured":"Phe K, Lee Y, McDaneld PM, Prasad N, Yin T, Figueroa DA, Musick WL, Cottreau JM, Hu M, Tam VH. In vitro assessment and multicentre cohort study of comparative nephrotoxicity rates associated with colistimethate versus Polymyxin B therapy. Antimicrob Agents Chemother. 2014;58:2740\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"262_CR5","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1093\/cid\/cit453","volume":"57","author":"DS Akajagbor","year":"2013","unstructured":"Akajagbor DS, Wilson SL, Shere-Wolfe KD, Dakum P, Charurat ME, Gilliam BL. Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with Polymyxin B in critically ill patients at a tertiary care medical center. Clin Infect Dis. 2013;57:1300\u20133.","journal-title":"Clin Infect Dis"},{"key":"262_CR6","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/cid\/civ717","volume":"61","author":"L Dalfino","year":"2015","unstructured":"Dalfino L, Puntillo F, Ondok MJ, Mosca A, Monno R, Coppolecchia S, Spada ML, Bruno F, Brienza N. Colistin-associated acute kidney injury in severely ill patients: a step toward a better renal care? A prospective cohort study. Clin Infect Dis. 2015;61:1771\u20137.","journal-title":"Clin Infect Dis"},{"key":"262_CR7","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3109\/00365548.2014.926021","volume":"46","author":"II Balkan","year":"2014","unstructured":"Balkan II, Dogan M, Durdu B, Batirel A, Hakyemez IN, Cetin B, et al. Colistin nephrotoxicity increases with age. Scand J Infect Dis. 2014;46:678\u201385.","journal-title":"Scand J Infect Dis"},{"issue":"7","key":"262_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.4103\/0972-5229.136070","volume":"18","author":"A Dewan","year":"2014","unstructured":"Dewan A, Shoukat M. Evaluation of risk of nephrotoxicity with high dose, extended-interval Colistin administration. Indian J Crit Care Med. 2014;18(7):427\u201330.","journal-title":"Indian J Crit Care Med."},{"key":"262_CR9","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1128\/AAC.02634-15","volume":"60","author":"MH Rigatto","year":"2016","unstructured":"Rigatto MH, Oliveira MS, Perdigao-Neto LV, Levin AS, Carrilho CM, Tanita MT, Tuon FF, Cardoso DE, Lopes NT, Falci DR, Zavascki AP. Multicenter prospective cohort study of renal failure in patients treated with Colistin versus Polymyxin B. Antimicrob Agents Chemother. 2016;60:2443\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"262_CR10","doi-asserted-by":"publisher","first-page":"R204","DOI":"10.1186\/cc2872","volume":"8","author":"R Bellomo","year":"2004","unstructured":"Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure\u2014definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit Care. 2004;8:R204\u201312.","journal-title":"Crit Care"},{"key":"262_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/cc7759","volume":"13","author":"DN Cruz","year":"2009","unstructured":"Cruz DN, Ricci Z, Ronco C. Clinical review: RIFLE and AKIN\u2013time for reappraisal. Crit Care. 2009;13:211.","journal-title":"Crit Care"},{"key":"262_CR12","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1186\/cc4915","volume":"10","author":"EA Hoste","year":"2006","unstructured":"Hoste EA, Clermont G, Kersten A, Venkataraman SR, Angus DC, De Bacquer D, Kellum JA. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006;10:R73.","journal-title":"Crit Care"},{"key":"262_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.diagmicrobio.2009.07.018","volume":"65","author":"MS Oliveira","year":"2009","unstructured":"Oliveira MS, Prado GV, Costa SF, Grinbaum RS, Levin AS. Polymyxin B and colistimethate are comparable as to efficacy and renal toxicity. Diagn Microbiol Infect Dis. 2009;65:431\u20134.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"262_CR14","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1128\/AAC.01707-09","volume":"54","author":"CA Deryke","year":"2010","unstructured":"Deryke CA, Crawford AJ, Uddin N, Wallace MR. Colistin dosing and nephrotoxicity in a large community teaching hospital. Antimicrob Agents Chemother. 2010;54:4503\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"262_CR15","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/cid\/cir611","volume":"53","author":"JM Pogue","year":"2011","unstructured":"Pogue JM, Lee J, Marchaim D, Yee V, Zhao JJ, Chopra T, et al. Incidence of and risk factors for Colistin-associated nephrotoxicity in a large academic health system. Clin Infect Dis. 2011;53:879\u201384.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"262_CR16","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00228-015-1865-4","volume":"71","author":"O Javan","year":"2015","unstructured":"Javan O, Shokouhi S, Sahraei Z. A review on Colistin nephrotoxicity. Eur J Clin Pharmacol. 2015;71(7):801\u201310.","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"262_CR17","doi-asserted-by":"publisher","first-page":"e02319-16","DOI":"10.1128\/AAC.02319-16","volume":"61","author":"AP Zavascki","year":"2017","unstructured":"Zavascki AP, Nation RL. Nephrotoxicity of polymyxins: is there any difference between colistimethate and Polymyxin B? Antimicrob Agents Chemother. 2017;61(3):e02319-16.","journal-title":"Antimicrob Agents Chemother"},{"key":"262_CR18","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1086\/599225","volume":"48","author":"JD Hartzell","year":"2009","unstructured":"Hartzell JD, Neff R, Ake J, et al. Nephrotoxicity associated with intravenous Colistin (colistimethate sodium) treatment at a tertiary care medical center. Clin Infect Dis. 2009;48:1724\u20138.","journal-title":"Clin Infect Dis"},{"key":"262_CR19","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/1471-2334-13-380","volume":"13","author":"L Sorli","year":"2013","unstructured":"Sorli L, Luque S, Grau S, Berenguer N, Segura C, Montero MM, Alvarez-Lerma F, Knobel H, Benito N, Horcajada JP. Trough Colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study. BMC Infect Dis. 2013;13:380.","journal-title":"BMC Infect Dis"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-018-0262-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12941-018-0262-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-018-0262-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T00:12:01Z","timestamp":1553299921000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-018-0262-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,23]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["262"],"URL":"https:\/\/doi.org\/10.1186\/s12941-018-0262-0","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,23]]},"assertion":[{"value":"14 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"15"}}